NEW YORK, January 24, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that one of its oncology thought leaders will be presenting at the Specialty Pharmaceutical Supply Chain Issues and Trends Seminar. The meeting will take place January 31-February 1, 2012, at the Adolphus in Dallas, Texas.
Gordon Gochenauer, Director, will present “Personalized Medicine: Biomarkers and the Advent of New Technologies to Determine Appropriate Care” from 4:15 to 5:15 pm on Tuesday, January 31. The session will give attendees the opportunity to discuss the impact of biomarkers on the specialty pharmaceutical supply chain, including what it means for manufacturers and distributors, distribution channels and product safety/supply chain efficiencies.
Mr. Gochenauer is part of Kantar Health's U.S. Oncology Commercial Strategies team. Previously, Mr. Gochenauer was co-leader of the CancerMPact® team with a primary responsibility for the Emerging Technologies, Treatment Architecture Japan, Treatment Architecture China, and Treatment Evolution Japan modules, which provide an in-depth review of the current cancer treatment trends and assessments of the future treatment evolution. Additionally, Mr. Gochenauer led syndicated research into the current and future treatment paradigms in the U.S. cancer market as well as research on the treatment and intervention of the supportive aspects of cancer treatment.
For more information on this event, please visit the conference website.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.